☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
paratek pharmaceuticals
Paratek Pharmaceuticals Reports Topline Results from P-IIb Study of Nuzyra (Omadacycline) for Nontuberculous Mycobacterial Abscess...
November 11, 2024
Load more...
Back to Home
Modal title
×
Modal body text goes here.